H.R. 3152 · 119th Congress · Commerce
Patent Eligibility Restoration Act of 2025
- IntroducedMay 1, 2025 Done
- CommitteeReferred to Judiciary Current stage
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
This bill amends the law relating to patent subject matter eligibility to establish that only specified subject matter (e.g., a natural process wholly independent of human activity) is ineligible for patenting. (Currently, subject matter eligibility is determined by examining whether the claimed invention is directed to certain ineligible categories, and if so, whether there is an inventive concept. Subject matter eligibility is one of several requirements that an invention must satisfy in order to receive patent protection.)
Under this bill, an invention shall be considered to involve patent-ineligible subject matter only if it falls within specified categories, such as (1) a mathematical formula that is not part of a useful process, machine, manufacture, or composition; (2) a mental process that is performed solely in the human mind; or (3) an unmodified human gene as the gene exists in the human body.
Congressional Research Service · summary of “Introduced in House” version · May 1, 2025
Who lobbies on it
17 organizations, more than 98% of House bills · 86 filings, incl. 17 naming only S. 1546 · Q2 2025–Q3 2026One square per quarter since introduction, oldest left. Filled = named H.R. 3152 or S. 1546 that quarter.
-
Pharmaceutical Research and Manufacturers of America
6 of 6 quarters
“S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent…”
$26.6M lobbying spend in 2026 to date, all issuesQ3 2026 filing · names both
-
Microsoft Corporation
6 of 6 quarters
“Software copyright and related policy issues. Software patents and related policy issues. S. 1553, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. S. 1546, Patent Eligibility Restoration Act. S. 1367, NO FAKES Act. S. 4098, AI Ready Data Act.”
$7.5M lobbying spend in 2026 to date, all issuesQ3 2026 filing · names S. 1546 only
-
Novartis
6 of 6 quarters
“…S. 1546/H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) Restrictions on Intellectual Property Rights PTAB reform Patent fee policy issues Section 101 reform”
$6.2M lobbying spend in 2026 to date, all issuesQ3 2026 filing · names both
14 more organizations, every filingPROUpgrade
Organizations that named H.R. 3152 or its companion S. 1546 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Reports naming only S. 1546 are included and tagged. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Members sponsoring the companion, S. 1546, are counted on that bill’s page, not here. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- May 1, 2025Referred to the House Committee on the Judiciary.
- May 1, 2025Introduced in House